Clinical Trials Directory

Trials / Terminated

TerminatedNCT06114303

Ex-vivo Evaluation of the Effect of 2 Probiotic Solutions (Lactibiane ATB and Lactibiane Enfant) and 5 Classes of Drugs on the Intestinal Microbiota

Status
Terminated
Phase
Study type
Observational
Enrollment
14 (actual)
Sponsor
Larena SAS · Industry
Sex
Female
Age
1 Year – 40 Years
Healthy volunteers
Accepted

Summary

The objective is to test ex-vivo the effects of two probiotic solutions (Lactibiane ATB and Lactibiane Enfant) and five classes of drugs (antibiotic, proton pump inhibitor, non-steroidal anti-inflammatory, anxiolytic and anti-depressant) on microbial microcosms derived from human stool samples (from adults and children) re-cultured under anaerobic conditions.

Conditions

Interventions

TypeNameDescription
OTHERStool sampling1 stool sample is taken during the study with a stool sample kit

Timeline

Start date
2024-03-14
Primary completion
2025-06-16
Completion
2025-06-16
First posted
2023-11-02
Last updated
2025-12-02

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06114303. Inclusion in this directory is not an endorsement.